Pre-order Enquiry
Request Free Sample
Global Postoperative Nausea and Vomiting (PONV) Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18491403 | Publishing Date : 10-Jun-2021 | No. of pages : 106
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Postoperative Nausea and Vomiting (PONV) Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Postoperative Nausea and Vomiting (PONV)1.1 Postoperative Nausea and Vomiting (PONV) Market Overview
1.1.1 Postoperative Nausea and Vomiting (PONV) Product Scope
1.1.2 Postoperative Nausea and Vomiting (PONV) Market Status and Outlook
1.2 Global Postoperative Nausea and Vomiting (PONV) Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2027)
1.4 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2016-2021)
1.5 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
1.6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
1.6.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
1.6.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
1.6.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
1.6.5 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
2 Postoperative Nausea and Vomiting (PONV) Market Overview by Type
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2016-2021)
2.3 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027)
2.4 Serotonin Antagonists
2.5 Steroids
2.6 Dopamine Antagonists
2.7 NK-1 Receptor Antagonists
2.8 Non-pharmacologic Treatment
2.9 Others
3 Postoperative Nausea and Vomiting (PONV) Market Overview by Application
3.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2016-2021)
3.3 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027)
3.4 Hospital Pharmacies
3.5 Online Pharmacies
3.6 Retail Pharmacies
4 Postoperative Nausea and Vomiting (PONV) Competition Analysis by Players
4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020)
4.3 Date of Key Players Enter into Postoperative Nausea and Vomiting (PONV) Market
4.4 Global Top Players Postoperative Nausea and Vomiting (PONV) Headquarters and Area Served
4.5 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
4.6 Competitive Status
4.6.1 Postoperative Nausea and Vomiting (PONV) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Acacia Pharma
5.1.1 Acacia Pharma Profile
5.1.2 Acacia Pharma Main Business
5.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.1.5 Acacia Pharma Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.3.5 Ani Pharmaceuticals Recent Developments
5.4 Ani Pharmaceuticals
5.4.1 Ani Pharmaceuticals Profile
5.4.2 Ani Pharmaceuticals Main Business
5.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.4.5 Ani Pharmaceuticals Recent Developments
5.5 Camurus
5.5.1 Camurus Profile
5.5.2 Camurus Main Business
5.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.5.5 Camurus Recent Developments
5.6 Sanofi
5.6.1 Sanofi Profile
5.6.2 Sanofi Main Business
5.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.6.5 Sanofi Recent Developments
5.7 Helsinn Holding
5.7.1 Helsinn Holding Profile
5.7.2 Helsinn Holding Main Business
5.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.7.5 Helsinn Holding Recent Developments
5.8 Eisai
5.8.1 Eisai Profile
5.8.2 Eisai Main Business
5.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.8.5 Eisai Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.9.5 Merck Recent Developments
5.10 GlaxoSmithKline
5.10.1 GlaxoSmithKline Profile
5.10.2 GlaxoSmithKline Main Business
5.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
5.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) & (2016-2021)
5.10.5 GlaxoSmithKline Recent Developments
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Postoperative Nausea and Vomiting (PONV) Market Dynamics
11.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
11.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
11.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
11.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Postoperative Nausea and Vomiting (PONV) Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Region (2016-2021)
Table 4. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021)
Table 9. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027)
Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2016-2021)
Table 14. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2022-2027)
Table 16. Global Postoperative Nausea and Vomiting (PONV) Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020)
Table 19. Date of Key Manufacturers Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 20. Global Postoperative Nausea and Vomiting (PONV) Top Players Headquarters and Area Served
Table 21. Postoperative Nausea and Vomiting (PONV) Product Solution and Service
Table 22. Global Postoperative Nausea and Vomiting (PONV) Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Acacia Pharma Basic Information List
Table 25. Acacia Pharma Description and Business Overview
Table 26. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 27. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Acacia Pharma (2016-2021)
Table 28. Acacia Pharma Recent Developments
Table 29. F. Hoffmann-La Roche Basic Information List
Table 30. F. Hoffmann-La Roche Description and Business Overview
Table 31. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 32. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of F. Hoffmann-La Roche (2016-2021)
Table 33. F. Hoffmann-La Roche Recent Developments
Table 34. Novartis Basic Information List
Table 35. Novartis Description and Business Overview
Table 36. Novartis Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 37. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Novartis (2016-2021)
Table 38. Novartis Recent Developments
Table 39. Ani Pharmaceuticals Basic Information List
Table 40. Ani Pharmaceuticals Description and Business Overview
Table 41. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 42. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Ani Pharmaceuticals (2016-2021)
Table 43. Ani Pharmaceuticals Recent Developments
Table 44. Camurus Basic Information List
Table 45. Camurus Description and Business Overview
Table 46. Camurus Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 47. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Camurus (2016-2021)
Table 48. Camurus Recent Developments
Table 49. Sanofi Basic Information List
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 52. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Sanofi (2016-2021)
Table 53. Sanofi Recent Developments
Table 54. Helsinn Holding Basic Information List
Table 55. Helsinn Holding Description and Business Overview
Table 56. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 57. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Helsinn Holding (2016-2021)
Table 58. Helsinn Holding Recent Developments
Table 59. Eisai Basic Information List
Table 60. Eisai Description and Business Overview
Table 61. Eisai Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 62. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Eisai (2016-2021)
Table 63. Eisai Recent Developments
Table 64. Merck Basic Information List
Table 65. Merck Description and Business Overview
Table 66. Merck Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 67. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of Merck (2016-2021)
Table 68. Merck Recent Developments
Table 69. GlaxoSmithKline Basic Information List
Table 70. GlaxoSmithKline Description and Business Overview
Table 71. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Products, Services and Solutions
Table 72. Revenue (US$ Million) in Postoperative Nausea and Vomiting (PONV) Business of GlaxoSmithKline (2016-2021)
Table 73. GlaxoSmithKline Recent Developments
Table 74. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2016-2021)
Table 81. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2022-2027)
Table 82. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 86. Postoperative Nausea and Vomiting (PONV) Market Trends
Table 87. Postoperative Nausea and Vomiting (PONV) Market Drivers
Table 88. Postoperative Nausea and Vomiting (PONV) Market Challenges
Table 89. Postoperative Nausea and Vomiting (PONV) Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions: 2021 VS 2027
Figure 4. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Type in 2021 & 2027
Figure 11. Serotonin Antagonists Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Steroids Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Dopamine Antagonists Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. NK-1 Receptor Antagonists Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Non-pharmacologic Treatment Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Others Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Application in 2021 & 2027
Figure 18. Hospital Pharmacies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Online Pharmacies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Retail Pharmacies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 21. Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Top 5 and Top 10 Players Postoperative Nausea and Vomiting (PONV) Market Share in 2020
Figure 23. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 24. United States Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 25. Canada Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 26. Germany Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 27. France Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 28. U.K. Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 29. Italy Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 30. Russia Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 31. Nordic Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 32. Rest of Europe Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2016-2027)
Figure 34. China Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 35. Japan Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 36. South Korea Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 37. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 38. India Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 39. Australia Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 40. Rest of Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 41. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 42. Mexico Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 43. Brazil Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 44. Rest of Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 46. Turkey Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 47. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 48. UAE Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 49. Rest of Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027) & (US$ Million)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Keyplayers in Global Postoperative Nausea and Vomiting (PONV) Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Acacia PharmaF. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
